시장보고서
상품코드
1147264

세계의 마이크로바이옴 치료 시장 - 규모, 점유율, 동향 분석, 기회, 예측(2018-2028년)

Microbiome Therapeutics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2018-2028, Segmented by Application ; By Type ; Region

발행일: | 리서치사: Blueweave Consulting | 페이지 정보: 영문 140 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 마이크로바이옴 치료 시장 규모는 2021년 9,128만 달러에서 2028년 7억 4,630만 달러에 이르렀으며, 2022년부터 2028년 기간 동안 CAGR 35% 놀라운 성장이 예상됩니다. 인간 마이크로바이옴을 이해하기 위한 연구개발 투자 증가, 언메트 메디컬 요구를 가진 환자 집단 치료를 위한 신규 마이크로바이옴 제품 개발에 있어서의 기술 진보 및 관민 조직간 콜라보레이션 분석 등 세계의 마이크로바이옴 시장이 기록적인 성장률로 확대될 가능성이 기대되고 있습니다.

세계의 마이크로바이옴 치료(Microbiome Therapeutics) 시장 조사 분석을 통해 시장 규모와 예측, 부문 분석, 지역 분석, 기업 프로필 등 정보를 제공합니다.

목차

제1장 조사 틀

제2장 주요 요약

제3장 세계의 마이크로바이옴 치료 시장 고찰

  • 업계 밸류체인 분석
  • DROC 분석
    • 성장 촉진 요인
      • 신제품 개발을 위한 마이크로바이옴 기술 진보
      • 표적 질환 유병률 증가
      • 인간 마이크로바이옴을 이해하기 위한 연구개발 증가
    • 억제 요인
      • 높은 개발비와 생산비
      • 부정적인 임상 데이터가 마이크로바이옴 일반적인 인식에 악영향을 미친다
    • 기회
      • 관민 제휴 강화
    • 과제
      • 전문지식 부족과 불충분한 연구
      • 엄격한 정부 규제
  • 기술 진보/최신 동향
  • 규제 틀
  • 포터의 5가지 경쟁요인 분석

제4장 세계의 마이크로바이옴 치료 시장 주요 요약

  • 시장 규모와 예측 : 금액별(2018-2028년)
    • 금액별(100만 달러)
  • 시장 점유율과 예측
    • 용도별
      • 염증성 장질환(IBD)
      • 당뇨병
      • 다발성 경화증
      • 류마티스 관절
      • 기타
    • 유형별
      • 대변 미생물 이식
    • 지역별
      • 북미
      • 유럽
      • 아시아태평양(APAC)
      • 라틴아메리카
      • 중동·아프리카(MEA)

제5장 북미 마이크로바이옴 치료 시장

  • 시장 규모와 예측 : 금액별(2018-2028년)
    • 금액별(100만 달러)
  • 시장 점유율과 예측
    • 용도별
    • 유형별
    • 국가별
      • 미국
      • 캐나다

제6장 유럽 마이크로바이옴 치료 시장

  • 시장 규모와 예측 : 금액별(2018-2028년)
    • 금액별(100만 달러)
  • 시장 점유율과 예측
    • 유형별
    • 용도별
    • 국가별
      • 독일
      • 영국
      • 이탈리아
      • 프랑스
      • 스페인
      • 네덜란드
      • 벨기에
      • 북유럽 국가
      • 기타

제7장 아시아태평양 마이크로바이옴 치료 시장

  • 시장 규모와 예측 : 금액별(2018-2028년)
    • 금액별(100만 달러)
  • 시장 점유율과 예측
    • 유형별
    • 용도별
    • 국가별
      • 중국
      • 인도
      • 일본
      • 한국
      • 호주 뉴질랜드
      • 인도네시아
      • 말레이시아
      • 싱가포르
      • 필리핀
      • 베트남
      • 기타

제8장 라틴아메리카 마이크로바이옴 치료 시장

  • 시장 규모와 예측 : 금액별(2018-2028년)
    • 금액별(100만 달러)
  • 시장 점유율과 예측
    • 유형별
    • 용도별
    • 국가별
      • 브라질
      • 멕시코
      • 아르헨티나
      • 페루
      • 콜롬비아
      • 기타

제9장 중동·아프리카 마이크로바이옴 치료 시장

  • 시장 규모와 예측 : 금액별(2018-2028년)
    • 금액별(100만 달러)
  • 시장 점유율과 예측
    • 유형별
    • 용도별
    • 국가별
      • 사우디 아라비아
      • 아랍에미리트 연방
      • 카타르
      • 쿠웨이트
      • 이란
      • 남아프리카
      • 나이지리아
      • 케냐
      • 이집트
      • 모로코
      • 알제리
      • 기타

제10장 경쟁 상황

  • 주요 기업과 그 제품 목록
  • 세계의 마이크로바이옴 치료 기업 시장 점유율 분석(2021년)
  • 경쟁 벤치마킹 : 경영 파라미터별
  • 주요 전략 전개(합병, 인수, 파트너십)

제11장 세계의 마이크로바이옴 치료 시장 COVID-19 영향

제12장 기업 프로필(기업 주요 요약, 재무 매트릭스, 경쟁 상황, 주요 인원, 주요 경쟁 기업, 연락처 주소, 전략 전망, SWOT)

  • 4D Pharma Plc.
  • AOBiome LLC
  • AvidBiotics
  • Enterome SA
  • Evelo Biosciences
  • Ferring BV
  • Immuron Ltd.
  • LNC Therapeutics Inc.
  • Microbiome Therapeutics Inc.
  • Osel Inc.
  • OxThera AB
  • Rebiotix
  • Ritter Pharmaceuticals
  • Second Genome Therapeutics
  • SERES Therapeutics Inc.
  • Synlogic Inc.
  • Vedanta Biosciences Inc.
  • ViThera Pharmaceuticals Inc.
  • 기타

제13장 주요 전략 권장사항

제14장 조사 방법

NJH 22.11.15

Global Microbiome Therapeutics Market to Boom at Robust CAGR to Cross USD 746 Million by 2028

Global microbiome therapeutics market is expanding due to the increasing investments in R&D in understanding human microbiome and developing novel drugs to address significant unmet medical needs in target diseases.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Global Microbiome Therapeutics Market size at USD 91.28 million in 2021. During the forecast period between 2022 and 2028, BlueWeave expects global microbiome therapeutics market size to grow at a whopping CAGR of 35%, reaching a value of USD 746.3 million by 2028. Increasing investments in research and development to understand the human microbiome, technology advancements in developing novel microbiome products to treat growing patient populations with unmet medical needs, and collaborations between public and private organizations could propel the expansion of global microbiome market at a record growth rate during the period in analysis.

Global Microbiome Therapeutics Market - Overview

Microbiome is defined as the group of microorganisms, such as bacteria, fungi, and viruses, living in or on the human body. As a term, microbiome covers all of the genetic material within the community of microorganisms in a specific environment, for example, the human gut. It is estimated that there are nearly 100 trillion microbiomes in a healthy adult human body. Microbiomes has the potential to fight against the diseases. Many scientific research studies found that human gut microbiomes enhance the efficacy and safety of therapeutics. Hence, they are useful for developing human microbiome therapeutics.

The National Institutes of Health (NIH), the national medical research agency in the United States, launched the Human Microbiome Project (HMP), in 2007. The focus of HMP is to gather resources and gain required expertise to characterize the human microbiome and analyze its role in health and disease. The HMP is like a road map for finding the role played by microorganisms in human health, nutrition, immunity, and disease in many parts of the human body. The NIH earmarked a five-year budget of USD 170 million for the project. The HMP supports centers and institutes in the United States conducting research studies on the microbes living in skin, mouth, nose, colon, and vagina. About 80 institutes across the United States are conducting the HMP project.

In Europe, the European Commission funds a collaborative project called MetaHIT (METAgenomics of the Human Intestinal Tract) bringing together 15 institutes from eight countries in the region. The MetaHIT was established in 2012 to mainly focus on the potential of human microbiome therapeutics for inflammatory bowel syndrome (IBS) and obesity. The project's major results were the establishment of a catalogue of microbial genes from the human gut and the discovery of enterotypes.

Growing prevalence of target diseases

A main driver behind significant investments in R&D of human microbiome therapeutics is a surge in demand for the development of effective therapeutics for inflammatory bowel disease (IBD), metabolic disorders (such as diabetes and obesity), multiple sclerosis, and rheumatoid arthritis, and the prospects of novel microbiome drugs for significant product developments. For instance, the CDC reported that there were an estimated 1.3% adults (3 million) in the United States diagnosed with IBD (either Crohn's disease or ulcerative colitis) in 2015. There is significant unmet medical needs to address this target disease area alone. Hence, an increasing focus and R&D efforts on developing novel human microbiome therapeutics for treating targeted diseases could drive the global microbiome therapeutics market during the forecast period.

Challenges: High development costs and stringent regulations

The implementation of extremely sophisticated methods has been brought about by the requirement for clinical-grade, thoroughly polished final goods with high safety standards. The initial set of production units for such advanced technological methods involves substantial investments for the companies in the microbiome industry. The primary barrier to the rapid development of microbiome therapeutics for various targeted diseases is the strict regulatory requirements for sanctioning any new development related to the biopharmaceutical sector. The expansion of global microbiome therapeutics market is limited by the lack of comprehensive understanding of microbiomes and the testing and approval of therapeutics based on human microbiomes.

Impact of COVID-19 on Global Microbiome Therapeutics Market

COVID-19 pandemic highlighted the significance of developing novel drugs for comorbidities, including IBD and metabolic disorders (diabetes and obesity), for the world population. It, in turn, is expected to positively impact the discovery and development of microbiome therapeutics. However, the onset of COVID-19 pandemic and resultant lockdowns affected various clinical trials, including on the microbiome therapeutics, across the US and Europe. Post COVID-19 and relaxation of business and travel curbs could help accelerate the development of novel microbiome drugs.

Regional Insights

North America holds the highest market share and is expected to continue its dominance in the global microbiome therapeutics market. The presence of a sizable number of centers and institutes involved in the R&D of advanced medicines is one of the key factors for the growth of North America microbiome therapeutics market. The United States federal agencies' investments in the country's microbiome research are expected to boost the market's expansion in North America. Europe is the second largest region in the global microbiome therapeutics market. The European Commission's collaborative project, METAgenomics of the Human Intestinal Tract (MetaHIT) provides significant resources, expertise, and support for the development of microbiome therapeutics for IBD and metabolic disorders.

Competitive Landscape

The global microbiome therapeutics market includes prominent players, such as 4D Pharma Plc, AOBiome LLC, AvidBiotics, Enterome SA, Evelo Biosciences, Ferring B.V., Immuron Ltd., LNC Therapeutics Inc., Microbiome Therapeutics Inc., Osel Inc., OxThera AB, Rebiotix, Ritter Pharmaceuticals, Second Genome Therapeutics, SERES Therapeutics Inc., Synlogic Inc., Vedanta Biosciences Inc., and ViThera Pharmaceuticals Inc. These companies indulge in various strategies, including mergers and acquisitions, partnerships, joint ventures, licensing agreements, and collaborations, to discover and develop novel microbiome therapeutics for targeted diseases.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the global microbiome therapeutics market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the global microbiome therapeutics market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Type Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Microbiome Therapeutics Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Advancements in microbiome technology to develop novel products
      • 3.2.1.2. Growing prevalence of target diseases
      • 3.2.1.3. Increasing R&D to understand human microbiome
    • 3.2.2. Restraints
      • 3.2.2.1. High development and production costs
      • 3.2.2.2. Negative clinical data adversely affect public perception of microbiome
    • 3.2.3. Opportunity
      • 3.2.3.1. Strengthening collaboration between public and private organizations
    • 3.2.4. Challenges
      • 3.2.4.1. Lack of expertise and inadequate research
      • 3.2.4.2. Stringent government regulations
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Microbiome Therapeutics Market Overview

  • 4.1. Market Size & Forecast, by Value, 2018-2028
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Application
      • 4.2.1.1. Inflammatory Bowel Disease (IBD)
      • 4.2.1.2. Diabetes
      • 4.2.1.3. Multiple Sclerosis
      • 4.2.1.4. Rheumatoid Arthritis
      • 4.2.1.5. Others
    • 4.2.2. By Type
      • 4.2.2.1. Fecal Microbial Transplant
      • 4.2.2.2. Drugs
    • 4.2.3. By Region
      • 4.2.3.1. North America
      • 4.2.3.2. Europe
      • 4.2.3.3. Asia Pacific (APAC)
      • 4.2.3.4. Latin America
      • 4.2.3.5. Middle East and Africa (MEA)

5. North America Microbiome Therapeutics Market

    • 5.1.1. Market Size & Forecast, by Value, 2018-2028
    • 5.1.2. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application
    • 5.2.2. By Type
    • 5.2.3. By Country
      • 5.2.3.1. United States
      • 5.2.3.1.1. By Application
      • 5.2.3.1.2. By Type
      • 5.2.3.2. Canada
      • 5.2.3.2.1. By Application
      • 5.2.3.2.2. By Type

6. Europe Microbiome Therapeutics Market

  • 6.1. Market Size & Forecast, by Value, 2018-2028
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
      • 6.2.3.1. Germany
      • 6.2.3.1.1. By Application
      • 6.2.3.1.2. By Type
      • 6.2.3.2. United Kingdom
      • 6.2.3.2.1. By Application
      • 6.2.3.2.2. By Type
      • 6.2.3.3. Italy
      • 6.2.3.3.1. By Application
      • 6.2.3.3.2. By Type
      • 6.2.3.4. France
      • 6.2.3.4.1. By Application
      • 6.2.3.4.2. By Type
      • 6.2.3.5. Spain
      • 6.2.3.5.1. By Application
      • 6.2.3.5.2. By Type
      • 6.2.3.6. The Netherlands
      • 6.2.3.6.1. By Application
      • 6.2.3.6.2. By Type
      • 6.2.3.7. Belgium
      • 6.2.3.7.1. By Application
      • 6.2.3.7.2. By Type
      • 6.2.3.8. NORDIC Countries
      • 6.2.3.8.1. B By Application
      • 6.2.3.8.2. By Type
      • 6.2.3.9. Rest of Europe
      • 6.2.3.9.1. By Application
      • 6.2.3.9.2. By Type

7. Asia Pacific Microbiome Therapeutics Market

  • 7.1. Market Size & Forecast, by Value, 2018-2028
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
      • 7.2.3.1. China
      • 7.2.3.1.1. By Application
      • 7.2.3.1.2. By Type
      • 7.2.3.2. India
      • 7.2.3.2.1. By Application
      • 7.2.3.2.2. By Type
      • 7.2.3.3. Japan
      • 7.2.3.3.1. By Application
      • 7.2.3.3.2. By Type
      • 7.2.3.4. South Korea
      • 7.2.3.4.1. By Application
      • 7.2.3.4.2. By Type
      • 7.2.3.5. Australia & New Zealand
      • 7.2.3.5.1. By Application
      • 7.2.3.5.2. By Type
      • 7.2.3.6. Indonesia
      • 7.2.3.6.1. By Application
      • 7.2.3.6.2. By Type
      • 7.2.3.7. Malaysia
      • 7.2.3.7.1. By Application
      • 7.2.3.7.2. By Type
      • 7.2.3.8. Singapore
      • 7.2.3.8.1. By Application
      • 7.2.3.8.2. By Type
      • 7.2.3.9. Philippines
      • 7.2.3.9.1. By Application
      • 7.2.3.9.2. By Type
      • 7.2.3.10. Vietnam
      • 7.2.3.10.1. By Application
      • 7.2.3.10.2. By Type
      • 7.2.3.11. Rest of Asia Pacific
      • 7.2.3.11.1. By Application
      • 7.2.3.11.2. By Type

8. Latin America Microbiome Therapeutics Market

  • 8.1. Market Size & Forecast, by Value, 2018-2028
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
      • 8.2.3.1. Brazil
      • 8.2.3.1.1. By Application
      • 8.2.3.1.2. By Type
      • 8.2.3.2. Mexico
      • 8.2.3.2.1. By Application
      • 8.2.3.2.2. By Type
      • 8.2.3.3. Argentina
      • 8.2.3.3.1. By Application
      • 8.2.3.3.2. By Type
      • 8.2.3.4. Peru
      • 8.2.3.4.1. By Application
      • 8.2.3.4.2. By Type
      • 8.2.3.5. Colombia
      • 8.2.3.5.1. By Application
      • 8.2.3.5.2. By Type
      • 8.2.3.6. Rest of Latin America
      • 8.2.3.6.1. By Application
      • 8.2.3.6.2. By Type

9. Middle East & Africa Microbiome Therapeutics Market

  • 9.1. Market Size & Forecast, by Value, 2018-2028
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
      • 9.2.3.1. Saudi Arabia
      • 9.2.3.1.1. By Application
      • 9.2.3.1.2. By Type
      • 9.2.3.2. UAE
      • 9.2.3.2.1. By Application
      • 9.2.3.2.2. By Type
      • 9.2.3.3. Qatar
      • 9.2.3.3.1. By Application
      • 9.2.3.3.2. By Type
      • 9.2.3.4. Kuwait
      • 9.2.3.4.1. By Application
      • 9.2.3.4.2. By Type
      • 9.2.3.5. Iran
      • 9.2.3.5.1. By Application
      • 9.2.3.5.2. By Type
      • 9.2.3.6. South Africa
      • 9.2.3.6.1. By Application
      • 9.2.3.6.2. By Type
      • 9.2.3.7. Nigeria
      • 9.2.3.7.1. By Application
      • 9.2.3.7.2. By Type
      • 9.2.3.8. Kenya
      • 9.2.3.8.1. By Application
      • 9.2.3.8.2. By Type
      • 9.2.3.9. Egypt
      • 9.2.3.9.1. By Application
      • 9.2.3.9.2. By Type
      • 9.2.3.10. Morocco
      • 9.2.3.10.1. By Application
      • 9.2.3.10.2. By Type
      • 9.2.3.11. Algeria
      • 9.2.3.11.1. By Application
      • 9.2.3.11.2. By Type
      • 9.2.3.12. Rest of Middle East & Africa
      • 9.2.3.12.1. By Application
      • 9.2.3.12.2. By Type

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Microbiome Therapeutics Company Market Share Analysis, 2021
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)

11. Impact of Covid-19 on Global Microbiome Therapeutics Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT)

  • 12.1. 4D Pharma Plc.
  • 12.2. AOBiome LLC
  • 12.3. AvidBiotics
  • 12.4. Enterome SA
  • 12.5. Evelo Biosciences
  • 12.6. Ferring B.V.
  • 12.7. Immuron Ltd.
  • 12.8. LNC Therapeutics Inc.
  • 12.9. Microbiome Therapeutics Inc.
  • 12.10. Osel Inc.
  • 12.11. OxThera AB
  • 12.12. Rebiotix
  • 12.13. Ritter Pharmaceuticals
  • 12.14. Second Genome Therapeutics
  • 12.15. SERES Therapeutics Inc.
  • 12.16. Synlogic Inc.
  • 12.17. Vedanta Biosciences Inc.
  • 12.18. ViThera Pharmaceuticals Inc.
  • 12.19. Others

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations

*Financial in case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.

LOF

  • Figure 1 Global Microbiome Therapeutics Segmentation
  • Figure 2 Global Microbiome Therapeutics Market Value Chain Analysis
  • Figure 3 Company Share Analysis, 2021
  • Figure 4 Global Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 5 Global Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 6 Global Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 7 Global Microbiome Therapeutics Market Share, By Region, By Value, 2018-2028
  • Figure 8 North America Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 9 North America Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 10 North America Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 11 North America Microbiome Therapeutics Market Share, By Country, By Value, 2018-2028
  • Figure 12 United States Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 13 United States Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 14 United States Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 15 Canada Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 16 Canada Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 17 Canada Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 18 Europe Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 19 Europe Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 20 Europe Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 21 Europe Microbiome Therapeutics Market Share, By Country, By Value, 2018-2028
  • Figure 22 Germany Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 23 Germany Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 24 Germany Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 25 United Kingdom Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 26 United Kingdom Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 27 United Kingdom Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 28 Italy Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 29 Italy Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 30 Italy Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 31 France Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 32 France Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 33 France Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 34 Spain Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 35 Spain Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 36 Spain Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 37 The Netherlands Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 38 The Netherlands Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 39 The Netherlands Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 40 Belgium Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 41 Belgium Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 42 Belgium Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 43 NORDIC Countries Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 44 NORDIC Countries Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 45 NORDIC Countries Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 46 Rest of Europe Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 47 Rest of Europe Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 48 Rest of Europe Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 49 Asia-Pacific Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 50 Asia-Pacific Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 51 Asia-Pacific Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 52 Asia-Pacific Microbiome Therapeutics Market Share, By Country, By Value, 2018-2028
  • Figure 53 China Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 54 China Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 55 China Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 56 India Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 57 India Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 58 India Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 59 Japan Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 60 Japan Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 61 Japan Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 62 South Korea Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 63 South Korea Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 64 South Korea Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 65 Indonesia Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 66 Indonesia Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 67 Indonesia Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 68 Malaysia Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 69 Malaysia Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 70 Malaysia Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 71 Singapore Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 72 Singapore Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 73 Singapore Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 74 Philippines Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 75 Philippines Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 76 Philippines Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 77 Vietnam Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 78 Vietnam Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 79 Vietnam Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 80 Rest of Asia Pacific Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 81 Rest of Asia Pacific Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 82 Rest of Asia Pacific Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 83 Latin America Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 84 Latin America Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 85 Latin America Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 86 Latin America Microbiome Therapeutics Market Share, By Country, By Value, 2018-2028
  • Figure 87 Brazil Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 88 Brazil Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 89 Brazil Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 90 Mexico Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 91 Mexico Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 92 Mexico Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 93 Peru Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 94 Peru Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 95 Peru Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 96 Colombia Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 97 Colombia Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 98 Colombia Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 99 Rest of Latin America Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 100 Rest of Latin America Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 101 Rest of Latin America Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 102 Middle East & Africa Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 103 Middle East & Africa Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 104 Middle East & Africa Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 105 Middle East & Africa Microbiome Therapeutics Market Share, By Country, By Value, 2018-2028
  • Figure 106 Saudi Arabia Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 107 Saudi Arabia Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 108 Saudi Arabia Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 109 UAE Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 110 UAE Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 111 UAE Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 112 Qatar Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 113 Qatar Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 114 Qatar Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 115 Iran Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 116 Iran Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 117 Iran Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 118 Nigeria Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 119 Nigeria Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 120 Nigeria Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 121 Kenya Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 122 Kenya Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 123 Kenya Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 124 Egypt Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 125 Egypt Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 126 Egypt Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 127 Morocco Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 128 Morocco Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 129 Morocco Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 130 Algeria Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 131 Algeria Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 132 Algeria Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028
  • Figure 133 Rest of Middle East & Africa Microbiome Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 134 Rest of Middle East & Africa Microbiome Therapeutics Market Share, By Application, By Value, 2018-2028
  • Figure 135 Rest of Middle East & Africa Microbiome Therapeutics Market Share, By Type, By Value, 2018-2028

LOT

  • Table 1 Global Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 2 Global Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 3 Global Microbiome Therapeutics Market Size, By Region, By Value, 2018-2028
  • Table 4 North America Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 5 North America Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 6 United States Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 7 United States Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 8 Canada Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 9 Canada Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 10 Europe Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 11 Europe Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 12 Europe Microbiome Therapeutics Market Size, By Country, By Value, 2018-2028
  • Table 13 Germany Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 14 Germany Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 15 United Kingdom Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 16 United Kingdom Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 17 Italy Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 18 Italy Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 6 France Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 7 France Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 8 Spain Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 9 Spain Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 10 The Netherlands Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 11 The Netherlands Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 12 Belgium Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 13 Belgium Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 14 NORDIC Countries Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 15 NORDIC Countries Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 16 Rest of Europe Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 17 Rest of Europe Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 18 Asia-Pacific Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 19 Asia-Pacific Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 20 Asia-Pacific Microbiome Therapeutics Market Size, By Country, By Value, 2018-2028
  • Table 21 China Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 22 China Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 23 India Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 24 India Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 25 Japan Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 39 Japan Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 40 South Korea Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 41 South Korea Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 42 Indonesia Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 43 Indonesia Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 44 Malaysia Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 45 Malaysia Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 46 Singapore Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 47 Singapore Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 48 Philippines Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 49 Philippines Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 50 Vietnam Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 51 Vietnam Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 52 Rest of Asia Pacific Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 53 Rest of Asia Pacific Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 54 Latin America Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 55 Latin America Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 56 Latin America Microbiome Therapeutics Market Size, By Country, By Value, 2018-2028
  • Table 57 Brazil Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 58 Brazil Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 59 Mexico Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 60 Mexico Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 61 Peru Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 62 Peru Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 63 Colombia Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 64 Colombia Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 65 Rest of Latin America Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 66 Rest of Latin America Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 67 Middle East & Africa Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 68 Middle East & Africa Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 69 Middle East & Africa Microbiome Therapeutics Market Size, By Country, By Value, 2018-2028
  • Table 70 Saudi Arabia Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 71 Saudi Arabia Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 72 UAE Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 73 UAE Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 74 Qatar Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 75 Qatar Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 76 Iran Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 77 Iran Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 78 Nigeria Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 79 Nigeria Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 80 Kenya Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 81 Kenya Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 82 Egypt Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 83 Egypt Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 84 Morocco Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 85 Morocco Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 86 Algeria Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 87 Algeria Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 88 Rest of Middle East & Africa Microbiome Therapeutics Market Size, By Application, By Value, 2018-2028
  • Table 89 Rest of Middle East & Africa Microbiome Therapeutics Market Size, By Type, By Value, 2018-2028
  • Table 90 4D Pharma Plc. Company Overview
  • Table 91 4D Pharma Plc. Financial Overview
  • Table 92 AOBiome LLC Company Overview
  • Table 93 AOBiome LLC Financial Overview
  • Table 94 AvidBiotics Company Overview
  • Table 95 AvidBiotics Financial Overview
  • Table 96 Enterome SA Company Overview
  • Table 97 Enterome SA Financial Overview
  • Table 98 Evelo Biosciences Company Overview
  • Table 99 Evelo Biosciences Financial Overview
  • Table 100 Ferring B.V. Company Overview
  • Table 101 Ferring B.V. Financial Overview
  • Table 102 Immuron Ltd. Company Overview
  • Table 103 Immuron Ltd. Financial Overview
  • Table 104 LNC Therapeutics Inc. Company Overview
  • Table 105 LNC Therapeutics Inc. Financial Overview
  • Table 106 Microbiome Therapeutics Inc. Company Overview
  • Table 107 Microbiome Therapeutics Inc. Financial Overview
  • Table 108 Osel Inc. Company Overview
  • Table 109 Osel Inc. Financial Overview
  • Table 110 OxThera AB Company Overview
  • Table 111 OxThera AB Financial Overview
  • Table 112 SERES Therapeutics Inc. Company Overview
  • Table 113 SERES Therapeutics Inc. Financial Overview
  • Table 114 Synlogic Inc. Company Overview
  • Table 115 Synlogic Inc. Financial Overview
  • Table 116 Vedanta Biosciences Inc. Company Overview
  • Table 117 Vedanta Biosciences Inc. Financial Overview
  • Table 118 ViThera Pharmaceuticals Inc. Company Overview
  • Table 119 ViThera Pharmaceuticals Inc. Financial Overview
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제